Avior Wealth Management LLC raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 4.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,466 shares of the company’s stock after buying an additional 1,166 shares during the period. Avior Wealth Management LLC’s holdings in Option Care Health were worth $591,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. Sheets Smith Wealth Management boosted its stake in shares of Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock worth $553,000 after acquiring an additional 550 shares in the last quarter. Fort Washington Investment Advisors Inc. OH increased its stake in Option Care Health by 6.2% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 943,300 shares of the company’s stock worth $21,885,000 after purchasing an additional 54,830 shares in the last quarter. UMB Bank n.a. raised its holdings in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares during the period. Diversify Wealth Management LLC boosted its holdings in shares of Option Care Health by 31.7% in the fourth quarter. Diversify Wealth Management LLC now owns 13,560 shares of the company’s stock worth $325,000 after buying an additional 3,261 shares during the period. Finally, Wedge Capital Management L L P NC purchased a new position in shares of Option Care Health in the fourth quarter worth approximately $3,245,000. Institutional investors and hedge funds own 98.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on OPCH. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Barrington Research upped their price target on Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a research report on Thursday. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.
Option Care Health Trading Up 1.1 %
Shares of NASDAQ OPCH opened at $30.33 on Friday. The stock has a market cap of $5.16 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.11 and a beta of 1.31. The business has a 50 day simple moving average of $24.42 and a 200 day simple moving average of $27.82. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63.
Insiders Place Their Bets
In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.64% of the company’s stock.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Five stocks we like better than Option Care Health
- How to buy stock: A step-by-step guide for beginners
- Bloom Energy: Powering the Future With Decentralized Energy
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.